Thalomid

Covered Uses:	All FDA approved indications not otherwise excluded from Part D. Additional coverage for off-label uses include Crohn's disease, aphthous ulcers in the presence of HIV or AIDS, prostate cancer, malignant melanoma, myelofibrosis, myelodysplastic syndromes, and advanced hepatocellular carcinoma.
Exclusion Criteria:
Required Medical Information:
Age Restrictions:
Prescriber Restrictions:
Coverage Duration:	12 months
Other Criteria:

Last Modified on 12/21/2012